Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PERLA TL Posterior Osteosynthesis System

K-Number: K203222 · 2020-12-17

ApplicantSpineart
Decision Date2020-12-17
Product CodeNKB
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

PERLA TL Posterior Osteosynthesis System is the device name listed in this FDA 510(k) record. The listed applicant is Spineart. It received FDA 510(k) clearance on 2020-12-17 under 510(k) number K203222. The device is classified under product code NKB. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PERLA TL Posterior Osteosynthesis System?

PERLA TL Posterior Osteosynthesis System is a medical device that received FDA 510(k) clearance on 2020-12-17. The listed applicant is Spineart. The 510(k) number is K203222.

When did PERLA TL Posterior Osteosynthesis System receive FDA 510(k) clearance?

PERLA TL Posterior Osteosynthesis System received FDA 510(k) clearance on 2020-12-17, under 510(k) number K203222.

Who is the listed applicant for PERLA TL Posterior Osteosynthesis System?

The FDA 510(k) record lists Spineart as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PERLA TL Posterior Osteosynthesis System?

The FDA product code for PERLA TL Posterior Osteosynthesis System is NKB.

Other records listing Spineart as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 36 devices →

Related Devices (Code: NKB)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.